Vaccine Equity in SCD Study
Now open to participation.
Given the wide-ranging reasons for vaccine hesitancy, there is a strong need for evidence-based, community-informed vaccine resources, especially for those affected by Sickle Cell Disease (SCD) who are susceptible to infections. Through its Vaccine Equity in SCD (VES) Study, the SCAGO intends to work with patients with SCD, their families, and caregivers, to co-design and implement a Vaccination Equity Strategy in SCD to support policymakers, health agencies, hospitals etc. with valuable insight to achieving vaccine equity (what works for the sickle cell community) and support the sickle cell disease community with fact-based vaccine information.
Make sure your voice is heard by participating in any one of the upcoming focus group sessions. The focus group sessions are available virtually and in person.
To compensate participants for attending a virtual focus group session, we will provide you with a $25 gift after the completion of the virtual session.
To compensate participants for attending an in-person focus session we will provide refreshments during the session as well as a gift of $50.
To register, use the QR code to access the registration form or send an email to research@sicklecellanemiaca.live-website.com.
Questions/comments can be directed to the VES Team at research@sicklecellanemiaca.live-website.com
